In recent years, the field of ophthalmology has witnessed a revolutionary transformation propelled by the integration of artificial intelligence (AI) with multimodal data analytics. The human eye, far more than a mere optical organ, serves as a vital microcosm that reflects both systemic microcirculation and neural activity. Capitalizing on this dual role, researchers are now leveraging vast, heterogeneous datasets acquired from diverse imaging and molecular modalities to glean unprecedented insights into ocular health and disease. A landmark review published in the prestigious journal Eye Discovery meticulously synthesizes the state-of-the-art computational methodologies that harness this multimodal data for clinical and research purposes. It outlines how AI-driven approaches are not only accelerating diagnostic accuracy but also paving the way for precision medicine in ophthalmology.
Central to the clinical workflow is imaging, which encompasses a spectrum from macroscopic to cellular-level visualization. Traditional fundus photography remains the cornerstone imaging modality widely utilized for screening conditions such as diabetic retinopathy, glaucoma, and cataracts. The adoption of AI in analyzing these color fundus photographs has enhanced the sensitivity and specificity of lesion detection dramatically. Complementary imaging techniques include red-free fundus photography, which better resolves superficial vascular structures, enabling earlier identification of glaucomatous changes. Furthermore, ultra-widefield imaging, empowered by AI algorithms, extends visualization to peripheral retinal regions previously difficult to capture, thereby facilitating comprehensive assessments of peripheral pathologies.
Angiographic modalities further enrich the diagnostic landscape, offering dynamic insight into retinal and choroidal vasculature. Fluorescein fundus angiography, when paired with AI-enabled segmentation tools, can automate the identification and quantitative analysis of critical features such as non-perfusion areas and microaneurysms. Similarly, indocyanine green angiography benefits from AI’s pattern recognition capabilities to improve detection accuracy of conditions like polypoidal choroidal vasculopathy—a notoriously challenging diagnosis. These angiographic advances allow clinicians to map microvascular changes with unprecedented precision.
Optical imaging technologies, particularly optical coherence tomography (OCT) and its angiographic counterpart (OCTA), introduce high-resolution cross-sectional and vascular flow visualization without the need for contrast agents. AI-powered OCT analysis algorithms facilitate automated measurement of intraretinal fluid accumulation, an important biomarker for diseases such as age-related macular degeneration and diabetic macular edema. OCTA offers a revolutionary, non-invasive capability to visualize capillary-level blood flow, and deeper still, adaptive optics OCT pushes the boundaries further by enabling microscopic imaging of photoreceptor cells. This progression from macroscopic to microscopic imaging exemplifies the profound depth of insight AI brings to ophthalmic diagnostics.
Beyond traditional imaging, additional modalities such as fundus autofluorescence and confocal scanning laser ophthalmoscopy offer metabolic and structural perspectives. Fundus autofluorescence, in particular, captures the metabolic state of retinal pigment epithelium (RPE) cells and assists in monitoring geographic atrophy in diseases like age-related macular degeneration. AI’s analytical prowess allows for automated longitudinal assessments, providing clinicians with vital information about disease progression. Meanwhile, laser scanning enhances image sharpness and structural clarity, supporting biomechanical analyses essential to understanding corneal and retinal pathophysiology.
Anterior segment imaging represents another frontier where AI has made impactful strides. Slit-lamp photographs, commonly used to examine the eye’s anterior structures, now benefit from AI algorithms capable of automatically grading cataract severity and detecting signs of corneal inflammation with remarkable accuracy. Ultrasound biomicroscopy, a specialized imaging technique for visualizing anterior chamber angle structures, complements clinical decision-making in glaucoma management through automated AI-assisted measurements, enhancing both efficiency and reproducibility in diagnosis.
While imaging offers a direct window into anatomical and pathological changes, non-imaging data is equally transformative, especially when decoded through AI for molecular insights. Genomic data analysis has evolved with AI facilitating the identification of risk loci—genetic variants associated with increased susceptibility to ocular diseases—as well as potential drug targets. Transcriptomic data, when mined using advanced AI, reveals differential gene expression patterns between diseased and healthy tissues, highlighting disease mechanisms at the cellular level. Proteomic analysis, empowered by AI, elucidates complex protein interaction networks, identifying key biomarkers that may serve diagnostic or therapeutic roles.
Metabolomics also benefits from AI algorithms that explore small molecular profiles in biological fluids such as blood or aqueous humor. Through these analyses, researchers have discovered novel metabolites implicated in intraocular pressure regulation, vital for understanding and treating glaucoma. Integration of electronic health records (EHR) into AI frameworks further enables phenotype extraction from vast clinical datasets, enhancing disease prediction and personalized management strategies.
The greatest potential lies in the fusion of these diverse data modalities, harnessing AI’s ability to integrate and synthesize complex datasets into holistic diagnostic models. Image-to-image integration techniques allow the transfer of learned features from one imaging modality—such as OCT—to conventional two-dimensional fundus photos, enriching routine screenings with deeper anatomical insights. Multimodal analysis of non-imaging molecular datasets combines genomic, transcriptomic, and proteomic information, constructing detailed biological blueprints and real-time execution profiles that enhance diagnostic robustness and interpretation in hereditary eye conditions.
Moreover, combining imaging and non-imaging data epitomizes the future of precision ophthalmology, where AI aligns phenotypic imaging characteristics with deep molecular profiles and unstructured clinical narratives. This comprehensive alignment not only improves diagnostic accuracy but also provides mechanistic insights into disease pathophysiology, guiding personalized therapeutic interventions.
Despite remarkable advancements, the review emphasizes that fundamental challenges remain. Data standardization across centers and devices is paramount to ensuring AI algorithms generalize well beyond their training environments. Algorithm robustness, interpretability, and the capability to emulate spatiotemporal responses characteristic of biological tissues represent frontiers for future research. The construction and curation of large, cross-center, multimodal databases will be critical to fuel the next wave of intelligent ophthalmic models.
This review marks a pivotal moment in ophthalmic research, illustrating the arc from traditional subjective clinical assessment toward an era defined by data-driven, AI-augmented decision-making. As digital transformation progresses, the fusion of diverse data streams through sophisticated computational frameworks promises to unravel the complexity of ocular diseases, ultimately delivering enhanced patient care worldwide.
Subject of Research: Not applicable
Article Title: Data-driven computational methods in ophthalmology: A multimodal perspective
News Publication Date: 13-May-2026
References: 10.1016/j.edisc.2026.100026
Image Credits: Shujie Zhang
Keywords
Eye, Eye diseases, Vision disorders, Health and medicine, Artificial intelligence
